Advertisement

Info Diabetologie

, Volume 9, Issue 2, pp 15–17 | Cite as

Typ-1- oder Typ-2-Diabetes und Proteinurie

Atorvastatin schützt die Nieren von Diabetespatienten

  • Emanuel Fritschka
journal club
  • 18 Downloads

Literatur

  1. 1.
    Campese VM, Park J. HMG-CoA-reductase inhibitors and the kidney. Kidney Int 2007; 71: 1215–22.Google Scholar
  2. 2.
    Haynes R, Lewis D, Emberson J et al.; SHARP Collaborative Group. Effects of lowering LDL cholesterol on progression of kidney disease. J Am Soc nephrol 2014; 25:1825–33.Google Scholar
  3. 3.
    Colhoun HM, Betteridge DJ, Durrington PN et al.; CARDS investigators. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin diabetes Study (CARDS). Am J Kidney Dis 2009; 54: 810–19.Google Scholar

Literatur

  1. de Zeeuw D, Anzalone DA, Cain VA et al. Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial. Lancet Diabetes Endocrinol 2015;3(3):181–90.Google Scholar

Copyright information

© Urban & Vogel 2015

Authors and Affiliations

  1. 1.Bad BrückenauDeutschland

Personalised recommendations